DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer
出版年份 2018 全文链接
标题
DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer
作者
关键词
Colorectal cancer, Immune checkpoints, PD-L1, Galectin-9, DNA methylation, Histone trimethylation
出版物
Clinical Epigenetics
Volume 10, Issue 1, Pages -
出版商
Springer Nature America, Inc
发表日期
2018-08-06
DOI
10.1186/s13148-018-0539-3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Results and challenges of immune checkpoint inhibitors in colorectal cancer
- (2018) Sheik Emambux et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer
- (2018) Varun Sasidharan Nair et al. Clinical Epigenetics
- Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells
- (2017) Varun Sasidharan Nair et al. IMMUNOLOGY AND CELL BIOLOGY
- Immune Checkpoints as a Target for Colorectal Cancer Treatment
- (2017) Alessandro Passardi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Intratumoral FoxP3+Helios+ Regulatory T Cells Upregulating Immunosuppressive Molecules Are Expanded in Human Colorectal Cancer
- (2017) Azharuddin Sajid Syed Khaja et al. Frontiers in Immunology
- PD-L1 expression in colorectal cancer is associated with microsatellite instability, BRAF mutation, medullary morphology and cytotoxic tumor-infiltrating lymphocytes
- (2016) Matthew W Rosenbaum et al. MODERN PATHOLOGY
- DNA Demethylation of the Foxp3 Enhancer Is Maintained through Modulation of Ten-Eleven-Translocation and DNA Methyltransferases
- (2016) Varun Sasidharan Nair et al. MOLECULES AND CELLS
- Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases
- (2015) Lydia G. M. van der Geest et al. CLINICAL & EXPERIMENTAL METASTASIS
- Immune Checkpoint Blockade in Cancer Therapy
- (2015) Michael A. Postow et al. JOURNAL OF CLINICAL ONCOLOGY
- Combination cancer immunotherapy and new immunomodulatory targets
- (2015) Kathleen M. Mahoney et al. NATURE REVIEWS DRUG DISCOVERY
- Loss of 5-hydroxymethylcytosine in cancer: Cause or consequence?
- (2014) Gabriella Ficz et al. GENOMICS
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- (2014) Matthew M. Gubin et al. NATURE
- Connections between TET proteins and aberrant DNA modification in cancer
- (2014) Yun Huang et al. TRENDS IN GENETICS
- TETonic shift: biological roles of TET proteins in DNA demethylation and transcription
- (2013) William A. Pastor et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Recurrent R-spondin fusions in colon cancer
- (2012) Somasekar Seshagiri et al. NATURE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Epigenetics and colorectal cancer
- (2011) Victoria Valinluck Lao et al. Nature Reviews Gastroenterology & Hepatology
- Epigenetic changes in colorectal cancer
- (2011) Yan Jia et al. Chinese Journal of Cancer
- Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21
- (2009) Sarah Derks et al. CARCINOGENESIS
- Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
- (2009) M. Tahiliani et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search